| Name | Title | Contact Details |
|---|
CICF`s mission is to inspire, support, and practice philanthropy, leadership, and service in our community. Through the generosity of thousands of donors, CICF is the steward for more than $500 million in charitable assets focusing on three areas that make central Indiana a better place to live for you and future generations: * Grant making from a variety of funds to other effective not-for-profits * Community leadership on issues like helping families overcome obstacles, creating great public spaces, and embracing our ethnic communities * Philanthropic advising to help people make their charitable giving more thoughtful and enjoyable Our work is centered on our vision for central Indiana`s future. We envision our community being: * recognized for its superior support to those in need, * acknowledged for its ability to develop, retain and attract educated, creative and community-minded citizens, * admired for being a remarkable place to live.
Cerebral Palsy Associations of New York State is a multi-service organization with 24 Affiliates. Our mission is to advocate and provide direct services with and for individuals with cerebral palsy and other significant disabilities. The Mission of Cerebral Palsy Associations of New York State (CP of NYS) is to advocate and provide direct services with and for individuals with cerebral palsy and other significant disabilities, and their families, throughout New York State, in order to promote lifelong opportunities and choices for independence, inclusion and enhanced quality of life.
Connecticut Naral Foundation is a Hartford, CT-based company in the Non-Profit sector.
Hontech Foundation-Med Techn is a Westford, MA-based company in the Non-Profit sector.
Driven by a vibrant, hopeful, and tireless community, the National Brain Tumor Society`s strategic initiatives and funded programs aim to improve an understanding of all brain tumors to transform research into new and effective treatments, as quickly as possible. To achieve these goals, we also foster collaboration with leaders in the private sector, government, and academia to drive systemic change within all facets of the drug discovery and development landscape.